News Medical on MSN5h
Vision loss risks in patients using popular GLP-1 medications raise concernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback